Oct-21-20 Upgrade
Argus
Hold → Buy
Jul-29-20 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$144
Jul-14-20 Upgrade
BofA Securities
Neutral → Buy
$142
Jun-09-20 Upgrade
Wells Fargo
Underweight → Equal Weight
$90 → $120
Jun-02-20 Upgrade
Deutsche Bank
Hold → Buy
$140
Apr-28-20 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$139
Apr-27-20 Upgrade
Wolfe Research
Underperform → Peer Perform
Apr-27-20 Upgrade
Citigroup
Neutral → Buy
$113 → $130
Mar-27-20 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$95
Jan-08-20 Initiated
Wells Fargo
Underweight
$100
Jan-07-20 Downgrade
Barclays
Overweight → Equal Weight
$106
Dec-19-19 Upgrade
BofA/Merrill
Underperform → Neutral
$94 → $110
Jul-15-19 Downgrade
Goldman
Neutral → Sell
$90 → $85
Apr-02-19 Upgrade
Jefferies
Hold → Buy
$93 → $107
Mar-18-19 Resumed
Credit Suisse
Neutral
$101 → $91
Jan-31-19 Downgrade
Argus
Buy → Hold
Jan-17-19 Initiated
UBS
Neutral
$90
Jan-03-19 Downgrade
BofA/Merrill
Neutral → Underperform
Dec-03-18 Downgrade
BofA/Merrill
Buy → Neutral
Nov-30-18 Downgrade
Goldman
Buy → Neutral
Mar-01-21 12:42AM
Feb-26-21 03:40PM
12:27PM
Feb-24-21 04:28PM
07:30AM
Feb-23-21 08:30AM
06:20AM
Feb-17-21 02:47PM
Feb-16-21 12:51PM
06:45AM
Feb-09-21 03:30PM
Feb-06-21 07:30AM
03:13AM
Feb-04-21 04:30PM
11:25AM
08:05AM
07:26AM
06:54AM
06:45AM
06:35AM
06:30AM
Feb-03-21 04:19PM
Feb-01-21 11:27AM
09:46AM
Jan-29-21 11:34AM
05:57AM
Jan-28-21 12:32PM
10:08AM
Jan-26-21 03:28PM
Jan-22-21 06:35AM
Jan-20-21 06:18AM
Jan-19-21 10:17AM
Jan-18-21 01:46PM
09:49AM
07:34AM
07:01AM
Jan-14-21 11:51AM
07:48AM
Jan-13-21 03:18PM
10:35AM
09:52AM
Jan-11-21 05:45PM
Jan-06-21 12:10PM
Jan-05-21 05:50PM
Jan-01-21 11:30AM
Dec-30-20 07:14AM
Dec-29-20 05:50PM
Dec-28-20 10:55AM
Dec-23-20 12:55AM
Dec-22-20 11:50AM
11:40AM
06:45AM
Dec-21-20 05:45PM
Dec-17-20 05:40PM
03:07PM
07:05AM
Dec-16-20 07:01AM
06:45AM
Dec-14-20 05:45PM
02:39PM
Dec-09-20 11:23AM
08:03AM
Dec-07-20 12:02PM
Dec-02-20 11:59PM
10:40AM
Nov-25-20 08:59AM
Nov-24-20 07:30AM
Nov-23-20 06:39PM Investor's Business Daily
06:45AM
Nov-21-20 11:30AM
Nov-18-20 06:30PM
11:06AM
Nov-17-20 12:06PM
Nov-13-20 05:58AM
Nov-11-20 10:28AM Investor's Business Daily
Nov-03-20 01:58PM
Nov-02-20 07:47AM
Oct-28-20 07:30PM Investor's Business Daily
10:58AM Investor's Business Daily
10:01AM
Oct-27-20 11:09AM
07:30AM
Oct-26-20 10:05PM
Oct-24-20 10:04AM
Oct-22-20 04:34PM Investor's Business Daily
04:30PM
02:22PM
01:14PM
01:08PM Investor's Business Daily
01:08PM
10:43AM
08:05AM
07:15AM
07:08AM
06:45AM
Oct-21-20 08:40AM
Oct-17-20 06:43AM
01:08AM
Oct-16-20 09:58AM
09:57AM
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Athena Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated has a strategic collaboration with hc1; and strategic relationships with Clinical Genomics Pty Ltd and Anthem Inc. The company was founded in 1967 and is headquartered in Secaucus, New Jersey.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
PREVOZNIK MICHAEL E SVP & General Counsel Feb 25 Sale 115.49 801 92,507 40,152 Mar 01 04:29 PM PREVOZNIK MICHAEL E SVP & General Counsel Feb 24 Sale 116.95 1,188 138,937 40,953 Feb 25 04:39 PM GUINAN MARK Executive Vice President & CFO Dec 24 Option Exercise 66.51 81,756 5,437,592 155,335 Dec 28 04:27 PM GUINAN MARK Executive Vice President & CFO Dec 24 Sale 120.37 81,756 9,840,673 73,579 Dec 28 04:27 PM WILENSKY GAIL R Director Nov 24 Option Exercise 57.67 6,111 352,391 22,593 Nov 27 04:38 PM WILENSKY GAIL R Director Nov 24 Sale 126.02 6,111 770,120 16,482 Nov 27 04:38 PM STANZIONE DANIEL Director Nov 23 Sale 126.30 11,223 1,417,459 28,349 Nov 24 04:31 PM DEPPE MICHAEL J VP, Corp. Controller & CAO Oct 21 Option Exercise 57.25 10,450 598,244 35,485 Oct 23 04:42 PM DEPPE MICHAEL J VP, Corp. Controller & CAO Oct 21 Sale 125.00 10,450 1,306,250 25,090 Oct 23 04:42 PM RUSCKOWSKI STEPHEN H Chairman, CEO and President Oct 16 Option Exercise 66.51 291,997 19,420,720 529,744 Oct 19 04:17 PM RUSCKOWSKI STEPHEN H Chairman, CEO and President Oct 16 Sale 120.00 291,997 35,039,640 237,747 Oct 19 04:17 PM PREVOZNIK MICHAEL E SVP & General Counsel Oct 14 Option Exercise 52.17 35,591 1,856,605 75,678 Oct 15 04:45 PM PREVOZNIK MICHAEL E SVP & General Counsel Oct 14 Sale 119.00 35,591 4,235,329 40,087 Oct 15 04:45 PM Doherty Catherine T. SVP, Group Exec. Clin. Fran. Sep 02 Option Exercise 66.51 58,392 3,883,652 126,803 Sep 04 04:18 PM Doherty Catherine T. SVP, Group Exec. Clin. Fran. Sep 02 Sale 110.60 58,392 6,458,343 68,411 Sep 04 04:18 PM RING TIMOTHY M Director Jun 08 Option Exercise 58.50 11,730 686,209 32,235 Jun 10 04:31 PM GUINAN MARK Executive Vice President & CFO Jun 08 Option Exercise 71.17 72,596 5,166,657 146,175 Jun 10 04:33 PM GUINAN MARK Executive Vice President & CFO Jun 08 Sale 117.23 72,596 8,510,585 73,579 Jun 10 04:33 PM RING TIMOTHY M Director Jun 08 Sale 116.60 11,730 1,367,718 20,505 Jun 10 04:31 PM RUSCKOWSKI STEPHEN H Chairman, CEO and President Apr 27 Option Exercise 71.17 11,717 833,899 249,464 Apr 28 04:45 PM RUSCKOWSKI STEPHEN H Chairman, CEO and President Apr 27 Sale 112.01 11,717 1,312,433 237,747 Apr 28 04:45 PM EGLINTON MANNER CARRIE SVP, Advanced Diagnostics Apr 27 Sale 111.02 5,000 555,075 22,390 Apr 28 04:37 PM Davis J. E. EVP, General Diagnostics Mar 16 Sale 87.75 3,513 308,251 38,086 Mar 17 04:37 PM PREVOZNIK MICHAEL E SVP & General Counsel Mar 11 Sale 104.25 2,175 226,744 40,087 Mar 12 05:00 PM Doherty Catherine T. SVP, Group Exec. Clin. Fran. Mar 11 Sale 104.25 2,501 260,729 68,411 Mar 12 04:57 PM RUSCKOWSKI STEPHEN H Chairman, CEO and President Mar 10 Option Exercise 71.17 100 7,117 237,847 Mar 12 04:55 PM RUSCKOWSKI STEPHEN H Chairman, CEO and President Mar 10 Sale 112.19 100 11,219 237,747 Mar 12 04:55 PM RUSCKOWSKI STEPHEN H Chairman, CEO and President Mar 06 Option Exercise 71.17 230,178 16,381,768 456,738 Mar 10 04:38 PM RUSCKOWSKI STEPHEN H Chairman, CEO and President Mar 06 Sale 112.67 230,178 25,934,978 226,560 Mar 10 04:38 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite